IntroductionVasculitis is an inflammatory disease with variable end-organ damage that is classified based on involvement of small, medium or large vessels.1 Leukocytoclastic vasculitis is a small-vessel vasculitis predominantly affecting dermal capillaries and venules, and often secondary to underlying systemic vasculitis, infection or drug exposure.1 Commonly implicated drugs include beta-lactam antibiotics and non-steroidal anti-inflammatory drugs,1 while calcium channel blockers and hydroxymethylglutaryl-coA reductase inhibitors (statins) have been rarely associated2-6 – with no previous formal case report for verapamil. We present a case of cutaneous leukocytoclastic vasculitis associated with recently initiated verapamil and atorvastatin.
